Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, February 04, 2016
AMRI has announced that Anthony J. Maddaluna, Executive Vice President of Pfizer Inc. and President of Pfizer Global Supply, has been elected to the AMRI Board of Directors, effective as of February 4, 2016.
read more
Wednesday, February 03, 2016
Eleven Biotherapeutics and Albumedix have entered into an agreement that will see Albumedix acquire Eleven’s proprietary Supermin® albumin variant assets.
read more
Wednesday, February 03, 2016
Mersana Therapeutics and Takeda Pharmaceutical Company have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate, XMT-1522, outside the United States and Canada.
read more
Wednesday, February 03, 2016
Admescope, a preclinical ADME-Tox Contract Research Organisation (CRO), has announced a launch of two new in vitro services. The new service additions, Uptakesubst and Uptakeinhib, are designed to investigate transporter-mediated drug-drug ...
read more
Wednesday, February 03, 2016
Dr. Reddy's Laboratories has announced that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, a drug-device combination product intended for the treatment of acute migraine episodes, with ...
read more
Tuesday, February 02, 2016
Catalent Pharma Solutions has announced that it will invest $4.6M to further expand its Singapore clinical supply facility by building new flexible GMP space for secondary packaging, doubling its ambient storage space, and quadrupling cold storage ...
read more
Tuesday, February 02, 2016
Patheon has announced the appointment of Steve Lam as senior vice president of the company’s biologics business.
read more
Tuesday, February 02, 2016
CRF Health, a provider of eCOA solutions for the life sciences industry, has announced that Peter van Tiggelen has been appointed as the company's Chief Financial Officer (CFO).
read more
Monday, February 01, 2016
Gilead Sciences has announced that, effective March 10, 2016, current Chairman and CEO John C. Martin, PhD will assume the role of Executive Chairman of the company. John F. Milligan, PhD, currently President and Chief Operating Officer, will be ...
read more
Monday, February 01, 2016
Eagle Pharmaceuticals has announced that the U.S. Food and Drug Administration ("FDA") has granted Fast Track designation to its RYANODEX® (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke (“EHS”), an ...
read more
Monday, February 01, 2016
WAVE Life Sciences Ltd., a genetic medicine company focused on advancing potential best-in-class stereopure nucleic acid therapies, has announced its plan to deliver six clinical programs by 2018.
read more
Monday, February 01, 2016
Bristol-Myers Squibb Company and Pfizer have announced that the companies have entered into a collaboration agreement with Portola Pharmaceuticals Inc. to develop and commercialize the investigational agent andexanet alfa in Japan. Andexanet alfa, ...
read more
Monday, February 01, 2016
Dr. Reddy's Laboratories has announcedthat the U.S. Food and Drug Administration tentative approval for Zenavod™ (doxycycline) Capsules, 40 mg. Zenavod is a tetracycline-class drug indicated for the treatment of only inflammatory lesions (papules and...
read more
Monday, February 01, 2016
Vetter, a contract development and manufacturing organization (CDMO) committed to providing customers with the manufacture of high quality drug products, has announced that following approximately two years of construction, its Schuetzenstrasse multi...
read more
Wednesday, January 27, 2016
Eli Lilly and Company has announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
read more